05Applications

From validated model to deployable offering

How the proof-point models get packaged into offerings a partner can actually deploy against. Two live verticals today.

Vertical 01 · deployed

Biomanufacturing & process engineering

A predictable, scalable cell- and process-design platform, in place of trial-and-error scale-up.

Over 90% of synthetic biology projects collapse at scale, and over 70% of FDA approval delays trace back to CMC/manufacturing issues. Omphalos builds virtual cells for industrial chassis — E. coli BL21, S. cerevisiae, and others — and runs the scale-up in silico before it’s run on the bench.

A cell or process engineer uploads strain and process data through Lifabrica; a virtual cell model is built, tested at target scale, and any bottleneck is diagnosed with a quantified fix — for example, an oxygen-limited P450 step at 200 L, with a suggested homolog swap or feed change and its expected titer gain.

  1. 01Upload strain and process data
  2. 02A virtual cell model is built
  3. 03Scale-up is run in silico
  4. 04The bottleneck is diagnosed, with a quantified fix
Vertical 02 · via Virtual Cell Consortium

Food & functional health

Extends the same virtual-microbe and virtual-human-cell technology into four fronts.

01

Virtual probiotics

Genome-to-metabolism digital twins of candidate strains; pre-screens pathogenicity and resistance-transfer risk, predicts functional metabolite output and gut colonization.
02

In silico toxicity & safety

Cell-level dose-response and tissue-specific exposure screening; supports animal-testing reduction and regulatory dossiers.
03

Functional-material mechanism

Causal, white-box simulation of compound-to-target binding, used to prioritize candidates before wet-lab extraction.
04

Personalized nutrition

Individual genome, transcriptome, and microbiome integrated into a digital twin to simulate diet and supplement response.